Jane Hsaio

BioZone Pharmaceutical, Inc. is a pharmaceutical company. The company operates through its subsidiary companies, which engage in the developing and manufacturing of drug products, cosmetic and beauty products. Its products consists OTC, Cosmetic & Beauty and Dietary Supplements. The OTC Products include hair conditioners, shampoos for treatment of eczema and psoriasis, external analgesics, skin protectants, anti-fungal, topical anesthetics, nasal sprays, wound care, acne, cough, cold, anti-itch and skin lightening products. The Cosmetic & Beauty Products consists AHA and Beta Hydroxy, instant firming serums, anti-aging, body lotions, eye creams, moisture creams and lotions, facial scrubs and facial masks. The Dietary Supplements include vitamins, minerals and herbal remedies. BioZone Pharmaceutical was founded on December 4, 2006 and is headquartered in Englewood Cliffs, NJ.

SafeStitch Medical, Inc. operates as a developmental stage FDA-registered medical device company, which is focused on the development of medical devices that manipulate tissues for the treatment of obesity, gastroesophageal reflux disease, hernia formation, esophageal obstructions, Barrett's Esophagus, upper gastrointestinal bleeding, and other intraperitoneal abnormalities through endoscopic and minimally invasive surgery. It products include AMID Stapler, SMART Dilator, and standard and airway bite blocks. AMID Stapler is used to fix mesh in place, which helps prevent the recurrence of a hernia. SMART Dilators are used when an endoscopy demonstrates the narrowing of the esophagus. The bite blocks are used to protect the endoscope used in transoral gastrointestinal procedures and are required in all such procedures. SafeStitch Medical was founded by Charles J. Filip and Jeffrey G. Spragens in August 1988 and is headquartered in Miami, FL.

The Group's principal activity is to merge, consolidation, reorganization, joint venture or licensing agreement with another corporation or entity. The Group is seeking opportunity with one or more firms which have recently commenced operations, or which wish to utilize the public marketplace in order to raise additional capital in order to expand into new products or markets, to develop a new product or service or for other corporate purposes.

SafeStitch Medical, Inc. operates as a developmental stage FDA-registered medical device company, which is focused on the development of medical devices that manipulate tissues for the treatment of obesity, gastroesophageal reflux disease, hernia formation, esophageal obstructions, Barrett's Esophagus, upper gastrointestinal bleeding, and other intraperitoneal abnormalities through endoscopic and minimally invasive surgery. It products include AMID Stapler, SMART Dilator, and standard and airway bite blocks. AMID Stapler is used to fix mesh in place, which helps prevent the recurrence of a hernia. SMART Dilators are used when an endoscopy demonstrates the narrowing of the esophagus. The bite blocks are used to protect the endoscope used in transoral gastrointestinal procedures and are required in all such procedures. SafeStitch Medical was founded by Charles J. Filip and Jeffrey G. Spragens in August 1988 and is headquartered in Miami, FL.

SafeStitch Medical, Inc. operates as a developmental stage FDA-registered medical device company, which is focused on the development of medical devices that manipulate tissues for the treatment of obesity, gastroesophageal reflux disease, hernia formation, esophageal obstructions, Barrett's Esophagus, upper gastrointestinal bleeding, and other intraperitoneal abnormalities through endoscopic and minimally invasive surgery. It products include AMID Stapler, SMART Dilator, and standard and airway bite blocks. AMID Stapler is used to fix mesh in place, which helps prevent the recurrence of a hernia. SMART Dilators are used when an endoscopy demonstrates the narrowing of the esophagus. The bite blocks are used to protect the endoscope used in transoral gastrointestinal procedures and are required in all such procedures. SafeStitch Medical was founded by Charles J. Filip and Jeffrey G. Spragens in August 1988 and is headquartered in Miami, FL.

The Group's principal activity is to merge, consolidation, reorganization, joint venture or licensing agreement with another corporation or entity. The Group is seeking opportunity with one or more firms which have recently commenced operations, or which wish to utilize the public marketplace in order to raise additional capital in order to expand into new products or markets, to develop a new product or service or for other corporate purposes.

The Group's principal activity is to merge, consolidation, reorganization, joint venture or licensing agreement with another corporation or entity. The Group is seeking opportunity with one or more firms which have recently commenced operations, or which wish to utilize the public marketplace in order to raise additional capital in order to expand into new products or markets, to develop a new product or service or for other corporate purposes.

SafeStitch Medical, Inc. operates as a developmental stage FDA-registered medical device company, which is focused on the development of medical devices that manipulate tissues for the treatment of obesity, gastroesophageal reflux disease, hernia formation, esophageal obstructions, Barrett's Esophagus, upper gastrointestinal bleeding, and other intraperitoneal abnormalities through endoscopic and minimally invasive surgery. It products include AMID Stapler, SMART Dilator, and standard and airway bite blocks. AMID Stapler is used to fix mesh in place, which helps prevent the recurrence of a hernia. SMART Dilators are used when an endoscopy demonstrates the narrowing of the esophagus. The bite blocks are used to protect the endoscope used in transoral gastrointestinal procedures and are required in all such procedures. SafeStitch Medical was founded by Charles J. Filip and Jeffrey G. Spragens in August 1988 and is headquartered in Miami, FL.

BioZone Pharmaceutical, Inc. is a pharmaceutical company. The company operates through its subsidiary companies, which engage in the developing and manufacturing of drug products, cosmetic and beauty products. Its products consists OTC, Cosmetic & Beauty and Dietary Supplements. The OTC Products include hair conditioners, shampoos for treatment of eczema and psoriasis, external analgesics, skin protectants, anti-fungal, topical anesthetics, nasal sprays, wound care, acne, cough, cold, anti-itch and skin lightening products. The Cosmetic & Beauty Products consists AHA and Beta Hydroxy, instant firming serums, anti-aging, body lotions, eye creams, moisture creams and lotions, facial scrubs and facial masks. The Dietary Supplements include vitamins, minerals and herbal remedies. BioZone Pharmaceutical was founded on December 4, 2006 and is headquartered in Englewood Cliffs, NJ.

DVM Pharmaceuticals, Inc. researches and developst veterinary pharmaceutical products. The company also manufactures dermatological and nutraceutical products. DVM Pharmaceuticals is headquartered in Miami. FL.

SafeStitch Medical, Inc. operates as a developmental stage FDA-registered medical device company, which is focused on the development of medical devices that manipulate tissues for the treatment of obesity, gastroesophageal reflux disease, hernia formation, esophageal obstructions, Barrett's Esophagus, upper gastrointestinal bleeding, and other intraperitoneal abnormalities through endoscopic and minimally invasive surgery. It products include AMID Stapler, SMART Dilator, and standard and airway bite blocks. AMID Stapler is used to fix mesh in place, which helps prevent the recurrence of a hernia. SMART Dilators are used when an endoscopy demonstrates the narrowing of the esophagus. The bite blocks are used to protect the endoscope used in transoral gastrointestinal procedures and are required in all such procedures. SafeStitch Medical was founded by Charles J. Filip and Jeffrey G. Spragens in August 1988 and is headquartered in Miami, FL.

The Group's principal activity is to merge, consolidation, reorganization, joint venture or licensing agreement with another corporation or entity. The Group is seeking opportunity with one or more firms which have recently commenced operations, or which wish to utilize the public marketplace in order to raise additional capital in order to expand into new products or markets, to develop a new product or service or for other corporate purposes.

SafeStitch Medical, Inc. operates as a developmental stage FDA-registered medical device company, which is focused on the development of medical devices that manipulate tissues for the treatment of obesity, gastroesophageal reflux disease, hernia formation, esophageal obstructions, Barrett's Esophagus, upper gastrointestinal bleeding, and other intraperitoneal abnormalities through endoscopic and minimally invasive surgery. It products include AMID Stapler, SMART Dilator, and standard and airway bite blocks. AMID Stapler is used to fix mesh in place, which helps prevent the recurrence of a hernia. SMART Dilators are used when an endoscopy demonstrates the narrowing of the esophagus. The bite blocks are used to protect the endoscope used in transoral gastrointestinal procedures and are required in all such procedures. SafeStitch Medical was founded by Charles J. Filip and Jeffrey G. Spragens in August 1988 and is headquartered in Miami, FL.

SafeStitch Medical, Inc. operates as a developmental stage FDA-registered medical device company, which is focused on the development of medical devices that manipulate tissues for the treatment of obesity, gastroesophageal reflux disease, hernia formation, esophageal obstructions, Barrett's Esophagus, upper gastrointestinal bleeding, and other intraperitoneal abnormalities through endoscopic and minimally invasive surgery. It products include AMID Stapler, SMART Dilator, and standard and airway bite blocks. AMID Stapler is used to fix mesh in place, which helps prevent the recurrence of a hernia. SMART Dilators are used when an endoscopy demonstrates the narrowing of the esophagus. The bite blocks are used to protect the endoscope used in transoral gastrointestinal procedures and are required in all such procedures. SafeStitch Medical was founded by Charles J. Filip and Jeffrey G. Spragens in August 1988 and is headquartered in Miami, FL.

SafeStitch Medical, Inc. operates as a developmental stage FDA-registered medical device company, which is focused on the development of medical devices that manipulate tissues for the treatment of obesity, gastroesophageal reflux disease, hernia formation, esophageal obstructions, Barrett's Esophagus, upper gastrointestinal bleeding, and other intraperitoneal abnormalities through endoscopic and minimally invasive surgery. It products include AMID Stapler, SMART Dilator, and standard and airway bite blocks. AMID Stapler is used to fix mesh in place, which helps prevent the recurrence of a hernia. SMART Dilators are used when an endoscopy demonstrates the narrowing of the esophagus. The bite blocks are used to protect the endoscope used in transoral gastrointestinal procedures and are required in all such procedures. SafeStitch Medical was founded by Charles J. Filip and Jeffrey G. Spragens in August 1988 and is headquartered in Miami, FL.

IVAX LLC discovers, develops, manufactures, and markets generic pharmaceuticals, respiratory drugs, and cancer treatments. It offers drugs for the treatment of multiple sclerosis, brain cancer, asthma, and epilepsy. The company was founded by Phillip Frost and Jane H. Hsiao in 1987 and is headquartered in Weston, FL.

The Group's principal activity is to merge, consolidation, reorganization, joint venture or licensing agreement with another corporation or entity. The Group is seeking opportunity with one or more firms which have recently commenced operations, or which wish to utilize the public marketplace in order to raise additional capital in order to expand into new products or markets, to develop a new product or service or for other corporate purposes.

SafeStitch Medical, Inc. operates as a developmental stage FDA-registered medical device company, which is focused on the development of medical devices that manipulate tissues for the treatment of obesity, gastroesophageal reflux disease, hernia formation, esophageal obstructions, Barrett's Esophagus, upper gastrointestinal bleeding, and other intraperitoneal abnormalities through endoscopic and minimally invasive surgery. It products include AMID Stapler, SMART Dilator, and standard and airway bite blocks. AMID Stapler is used to fix mesh in place, which helps prevent the recurrence of a hernia. SMART Dilators are used when an endoscopy demonstrates the narrowing of the esophagus. The bite blocks are used to protect the endoscope used in transoral gastrointestinal procedures and are required in all such procedures. SafeStitch Medical was founded by Charles J. Filip and Jeffrey G. Spragens in August 1988 and is headquartered in Miami, FL.

The Group's principal activity is to merge, consolidation, reorganization, joint venture or licensing agreement with another corporation or entity. The Group is seeking opportunity with one or more firms which have recently commenced operations, or which wish to utilize the public marketplace in order to raise additional capital in order to expand into new products or markets, to develop a new product or service or for other corporate purposes.

SafeStitch Medical, Inc. operates as a developmental stage FDA-registered medical device company, which is focused on the development of medical devices that manipulate tissues for the treatment of obesity, gastroesophageal reflux disease, hernia formation, esophageal obstructions, Barrett's Esophagus, upper gastrointestinal bleeding, and other intraperitoneal abnormalities through endoscopic and minimally invasive surgery. It products include AMID Stapler, SMART Dilator, and standard and airway bite blocks. AMID Stapler is used to fix mesh in place, which helps prevent the recurrence of a hernia. SMART Dilators are used when an endoscopy demonstrates the narrowing of the esophagus. The bite blocks are used to protect the endoscope used in transoral gastrointestinal procedures and are required in all such procedures. SafeStitch Medical was founded by Charles J. Filip and Jeffrey G. Spragens in August 1988 and is headquartered in Miami, FL.

SafeStitch Medical, Inc. operates as a developmental stage FDA-registered medical device company, which is focused on the development of medical devices that manipulate tissues for the treatment of obesity, gastroesophageal reflux disease, hernia formation, esophageal obstructions, Barrett's Esophagus, upper gastrointestinal bleeding, and other intraperitoneal abnormalities through endoscopic and minimally invasive surgery. It products include AMID Stapler, SMART Dilator, and standard and airway bite blocks. AMID Stapler is used to fix mesh in place, which helps prevent the recurrence of a hernia. SMART Dilators are used when an endoscopy demonstrates the narrowing of the esophagus. The bite blocks are used to protect the endoscope used in transoral gastrointestinal procedures and are required in all such procedures. SafeStitch Medical was founded by Charles J. Filip and Jeffrey G. Spragens in August 1988 and is headquartered in Miami, FL.

SafeStitch Medical, Inc. operates as a developmental stage FDA-registered medical device company, which is focused on the development of medical devices that manipulate tissues for the treatment of obesity, gastroesophageal reflux disease, hernia formation, esophageal obstructions, Barrett's Esophagus, upper gastrointestinal bleeding, and other intraperitoneal abnormalities through endoscopic and minimally invasive surgery. It products include AMID Stapler, SMART Dilator, and standard and airway bite blocks. AMID Stapler is used to fix mesh in place, which helps prevent the recurrence of a hernia. SMART Dilators are used when an endoscopy demonstrates the narrowing of the esophagus. The bite blocks are used to protect the endoscope used in transoral gastrointestinal procedures and are required in all such procedures. SafeStitch Medical was founded by Charles J. Filip and Jeffrey G. Spragens in August 1988 and is headquartered in Miami, FL.

IVAX LLC discovers, develops, manufactures, and markets generic pharmaceuticals, respiratory drugs, and cancer treatments. It offers drugs for the treatment of multiple sclerosis, brain cancer, asthma, and epilepsy. The company was founded by Phillip Frost and Jane H. Hsiao in 1987 and is headquartered in Weston, FL.

OPKO Biologics Ltd. develops next-generation, bio-better, long-acting versions of therapeutic proteins and peptide drugs. Its products include Human Growth Hormone, Glucagon dual receptor agonist, Factor VIIa and Factor IX for Hemophilia, Anti-Obesity Peptide Oxyntomodulin, Interferon and Erythropoietin, and Atherosclerosis and Rheumatoid Arthritis long-acting therapies. The company was founded by Novik A. Shai on August 22, 2003 and is headquartered in Nes Ziona, Israel.

IVAX LLC discovers, develops, manufactures, and markets generic pharmaceuticals, respiratory drugs, and cancer treatments. It offers drugs for the treatment of multiple sclerosis, brain cancer, asthma, and epilepsy. The company was founded by Phillip Frost and Jane H. Hsiao in 1987 and is headquartered in Weston, FL.

IVAX LLC discovers, develops, manufactures, and markets generic pharmaceuticals, respiratory drugs, and cancer treatments. It offers drugs for the treatment of multiple sclerosis, brain cancer, asthma, and epilepsy. The company was founded by Phillip Frost and Jane H. Hsiao in 1987 and is headquartered in Weston, FL.

OPKO Biologics Ltd. develops next-generation, bio-better, long-acting versions of therapeutic proteins and peptide drugs. Its products include Human Growth Hormone, Glucagon dual receptor agonist, Factor VIIa and Factor IX for Hemophilia, Anti-Obesity Peptide Oxyntomodulin, Interferon and Erythropoietin, and Atherosclerosis and Rheumatoid Arthritis long-acting therapies. The company was founded by Novik A. Shai on August 22, 2003 and is headquartered in Nes Ziona, Israel.

The Group's principal activity is to merge, consolidation, reorganization, joint venture or licensing agreement with another corporation or entity. The Group is seeking opportunity with one or more firms which have recently commenced operations, or which wish to utilize the public marketplace in order to raise additional capital in order to expand into new products or markets, to develop a new product or service or for other corporate purposes.